InfuSystem Holdings INFU
NYSE INFU
$12.21 +0.01 (+0.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Change in Accured Expenses came in at -$3.3 million in Q1 2026, down 111.03% YoY from $30.2 million in Q1 2025, and down 478.78% on a QoQ basis from -$575000.0 in Q4 2025.

InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 11 years of Change in Accured Expenses data on file, last reported at -$3.3 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 111.03% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 114.39% YoY) and the FY2025 annual result came in at -$708000.0, down 4.73% from the prior year.
  • Change in Accured Expenses retreated to -$3.3 million in Q1 2026, from -$575000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q4 2023 to a low of -$3.3 million in Q1 2026.
  • A 5-year average of $37941.2 and a median of $313000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 194.16% — and 2024, when it slumped 453.35%.
  • Tracing INFU's Change in Accured Expenses over 5 years: stood at $1.7 million in 2022, then jumped by 55.22% to $2.7 million in 2023, then sank by 79.55% to $553000.0 in 2024, then slumped by 203.98% to -$575000.0 in 2025, then sank by 478.78% to -$3.3 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$3.3 million (Q1 2026), -$575000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 298.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 234.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 123.70 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 112.90 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 19.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 43.01 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 4.80 Mn
10 InfuSystem Holdings 244.87 Mn 243.90 Mn 21.41 Mn 725,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 725,000.00
Jun 30, 2026 725,000.00
Mar 31, 2026 -3.33 Mn
Mar 31, 2026 -3.33 Mn
Dec 31, 2025 -575,000.00
Dec 31, 2025 -575,000.00
Sep 30, 2025 1.84 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 -398,000.00
Jun 30, 2025 -398,000.00
Mar 31, 2025 -1.58 Mn
Mar 31, 2025 -1.58 Mn
Dec 31, 2024 553,000.00
Dec 31, 2024 553,000.00
Sep 30, 2024 2.04 Mn
Sep 30, 2024 2.04 Mn
Jun 30, 2024 -2.16 Mn
Jun 30, 2024 -2.16 Mn
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn